Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy

Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy

Abstract Background Oxaliplatin + S-1 is a recognized treatment regimen in Japan, but there are no Japanese clinical data on an oxaliplatin dose of 130 mg/m2. The current research involves a single-arm, prospective, phase II clinical trial to examine the efficacy and safety of oxaliplatin + S-1 with...

Full description

Bibliographic Details
Main Authors: Hiroshi Saeki, Yasunori Emi, Eiji Oki, Shoji Tokunaga, Yoshihiro Kakeji, Yoshito Akagi, Hideo Baba, Eishi Baba, Yoshihiko Maehara, Kyushu Study group of Clinical Cancer (KSCC)
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Cancer
Subjects:
Metastatic gastric cancer
First-line chemotherapy
Oxaliplatin
S-1
Japanese patients
Online Access:http://link.springer.com/article/10.1186/s12885-017-3937-6

Internet

http://link.springer.com/article/10.1186/s12885-017-3937-6

Similar Items